Stock Price Quote

IND-SWIFT LABORATORIES LTD.

NSE : INDSWFTLABBSE : 532305ISIN CODE : INE915B01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE35.350.9 (+2.61 %)
PREV CLOSE ( ) 34.45
OPEN PRICE ( ) 33.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2784
TODAY'S LOW / HIGH ( )33.00 35.90
52 WK LOW / HIGH ( )15.25 47.6
NSE35.651.3 (+3.78 %)
PREV CLOSE( ) 34.35
OPEN PRICE ( ) 33.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 22419
TODAY'S LOW / HIGH( ) 33.40 35.95
52 WK LOW / HIGH ( )15 49.6
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 04-01 1995
Management Info
N R Munjal - Chairman N R Munjal - Managing Director
Registered Office

Address S C O 850,Shivalik Enclave, N A C,Manimajra,
Chandigarh,
Punjab-160101

Phone 172-2730503/2730920/5061850/51/52/53

Email investor@indswiftlabs.com

Website www.indswiftlabs.com

Registrars Details
Alankit Assignments Ltd.
205-208 , Anarkali Complex,Jhandewala Extension,,New Delhi
Listing : BSE, NSE, MCX

NEWS

12May IOC, Bharti Airtel and Ind-Swift Labor
Indian Oil Corporation (IOC) has raised operating levels at its refineri..
12May Ind-Swift Laboratories receives EIR fr
Ind-Swift Laboratories has received the Establishment Inspection Report..
12May Ind-Swift Laboratories touches roof on
Ind-Swift Laboratories is locked at upper circuit limit at Rs. 21.65, up..
16Mar Infosys, Wipro and Ind Swift Laborator
Infosys has completed the acquisition of Simplus, one of the fastest gro..
16Mar USFDA completes inspection at Ind Swif
United States Food and Drug Administration (USFDA) has completed inspect..

Financials

in Millions
QTR Mar 20 ANNUAL 20
Net Profit31.9299999999998-207.880000000001
Gross Profit 40.1499999999998 -195.610000000001
Operating Profit 474.911779.8
Net Sales 1850.397518.37

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr. Reddys Lab (BSE)
peergroup  3983.45 (2.18%)
M.Cap ( in Cr)66217.89
Alkem Laboratories (BSE)
peergroup  2477.75 (3.04%)
M.Cap ( in Cr)29625.22
Torrent Pharma (BSE)
peergroup  2420.25 (2.56%)
M.Cap ( in Cr)40952.74
Sanofi India (BSE)
peergroup  7674.75 (0.76%)
M.Cap ( in Cr)17675.43
Pfizer (BSE)
peergroup  4180.20 (1.14%)
M.Cap ( in Cr)19123.47

Shareholding Pattern

PROMOTERS 42%
NON-INSTITUTION 38.23%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
GS CNX 500(G)0.00

About Ind-Swift Laboratories Ltd.

Ind-Swift Laboratories Ltd. was incorporated in the year 1995. Its today's share price is 34.45. Its current market capitalisation stands at Rs 208.87 Cr. In the latest quarter, company has reported Gross Sales of Rs. 7599.15 Cr and Total Income of Rs.7928.51 Cr. The company's management includes Sahil Munjal, Ashwani K Vig, Neerja Chathley, Prabhat Khurana, S P Sharma, Rishav Mehta, Himanshu jain, N R Munjal, N R Munjal.

It is listed on the BSE with a BSE Code of 532305 , NSE with an NSE Symbol of INDSWFTLAB and ISIN of INE915B01019. It's Registered office is at S C O 850,Shivalik Enclave, N A C,ManimajraChandigarh-160101, Punjab. Their Registrars are ACC Ltd. It's auditors are Avishkar Singhal & Associates, Jain & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)